Lutetium-177 Treatment Cost in India
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Lutetium-177 PSMA Therapy, also known as Prostate-Specific Membrane Antigen Therapy, is becoming an increasingly popular therapy for men with advanced prostate cancer who have metastasis or have tumors that are resistant to other treatments.
Lu-PSMA therapy in India is a treatment for patients with advanced-stage prostate cancer or those who have not responded to traditional methods of therapy. The therapy is a highly accurate treatment that can help to protect healthy surrounding tissue while delivering high-dosage radiation to cancer cells.
The Cost of Lutetium-177 PSMA Therapy in India is quite affordable as compared to other developed countries. In India, the average price starts from USD. It is determined by the hospital room rates (Room Category – Multi-room, Twine Sharing, Single Room, and so on) as well as the doctor’s fee. The success rate of Lutetium-177 PSMA Therapy in India is extensively high.
Many prostate cancers, particularly those that have progressed or grown resistant to hormonal treatments, display a specific receptor termed Prostate Specific Membrane Antigen (PSMA) on their cell surface. When prostate cancer metastasizes or spreads to other parts of the body, the PSMA receptor is also expressed at the metastasis sites. PSMA is an excellent target for prostate cancer radionuclide imaging and therapy for various reasons:
Nuclear medicine Therapy in India is a technique for diagnosing and treating various types of disorders that involve just a small amount of radioactive material. Nuclear medicine is generally used to treat patients with thyroid tumors or hyperactive thyroid glands, neuroendocrine tumors, prostate cancers, lymphomas, and liver tumors.
A small amount of radioactive material or radioisotope, known as Radiopharmaceutical, is used in this targeted therapeutic strategy to kill cancer cells. To deposit fatal radiation into the tumor, the radioactive chemical is conjugated with a tumor-targeting agent. It can be taken as a drink, an injection, or a capsule.
Nuclear Medicine Therapy in India is provided by top prominent hospitals, including Fortis Memorial Research Institute. The Nuclear Medicine section at FMRI is a specialized unit prepared to perform several types of radioisotope therapy. It is the country’s referral institution for Iodine therapy for thyroid cancer and a pioneer in Lutetium therapies for neuroendocrine tumors. It is India’s first Lutetium PSMA therapy center and has treated many patients with this therapy. FMRI’s Nuclear Medicine department is now the only one in India to provide myeloablative MIBG therapy for high-risk neuroblastomas in children, as well as the first to provide Targeted alpha therapy for neuroendocrine tumors, prostate cancer, and certain brain tumors.
Lutetium-177 PSMA Treatment Cost in India start from INR 8,17,000 (9,800 USD) per course. A course on average, and a patient receiving lutetium-177 PSMA therapy will typically receive three or four courses. Lu-177 therapies, such as PSMA and PRRT therapy, are typically recommended to fourth-stage cancer patients after all other therapeutic options have been exhausted. These medicines improve patients’ health and standard of life, resulting in significantly higher survival rates.
Factors That Can Affect Lutetium-177 PSMA Treatment Cost in India
You may be eligible if you have prostate cancer that has gone beyond the prostate and has progressed despite prior treatments (including hormonal therapies and at least one chemotherapy). To ensure that you qualify for Treatment with Lutetium-177 PSMA in India, you must first have a PSMA PET scan, which is accessible in Best Nuclear Medicine Therapy Hospital in India.
Lutetium-177 PSMA Therapy Costs in India start from 9800 USD per course. A course on average, and a patient receiving lutetium-177 PSMA therapy will typically receive three or four courses. Lu-177 therapies, such as PSMA and PRRT therapy, are typically recommended to fourth-stage cancer patients after all other therapeutic options have been exhausted. These medicines improve patients' health and standard of life, resulting in significantly higher survival rates.
However, the overall Nuclear Medicine Therapy Cost in India starts from USD. The Treatment cost plan may differ from person to person and type of hospital chosen by the patient.
PSMA is a protein that is generated on the membrane of prostate cells and is believed to have a variety of biological activities. Although the prostatic epithelium produces very small amounts of PSMA normally, malignant prostate tumors produce extremely large amounts (sometimes 1,000 times more than a normal prostate cell). PSMA will be identified if prostate cancer has spread to other parts of the body.
Lutetium-177 is a radioactive material that emits beta radiation, which is a type of damaging radiation. Lutetium-177 binds to a short peptide that attaches to the PSMA receptor found on the surface of cancer cells. The Lutetium-177 PSMA complex, once attached to the prostate cancer cell, emits destructive radiation, causing the cancer cell to die. Because the released beta particle has a very low penetration, the surrounding normal cells are undisturbed.
Helpful - Best Nuclear Medicine Hospitals in India
This therapy improves the quantity and quality of life for patients who would otherwise have few treatment alternatives. Most patients who are suitable for this therapy are already suffering from cancer-related symptoms that are affecting their quality of life. As the majority of patients respond to the medication, their symptoms improve and their quality of life improves. It's also well tolerated, thus from a risk/benefit and quality of life standpoint, this medication is highly effective.
Medsurge India is a prestigious support system for patients looking for doctors, hospitals, and specialized treatments. We'll find the most suitable medical options for you. Regarding your medical issues, our team will give you a list of certified, reputable, and trusted doctors and hospitals. Additionally, we offer a treatment strategy that fits your budget. Apart, we assist patients with obtaining travel authorizations, medical visas, and a multitude of other things.
A: Although Lu-177 PSMA therapy is considered safe because the dose of Lutetium-177 radiation is carefully checked for each patient prior to treatment, some adverse effects might be predicted, including an increased risk of bleeding, Nausea, Dry Mouth.
A: You may be eligible if you have prostate cancer that has gone beyond the prostate and has progressed despite prior treatments (including hormonal therapies and at least one chemotherapy).
A: The mineral monazite, like many other lanthanides, is the primary source of lutetium. It is extracted by reducing anhydrous fluoride with calcium metal, which is a challenging process.
A: Ingestion of lutetium is mildly hazardous, however its insoluble salts are non-toxic. Lutetium, like other rare-earth metals, has a low toxicity rating, although it and its derivatives should be handled with caution.
A: Lutetium-177 therapy is only used on men who have prostate cancer and have exhausted all other treatment options. It has been shown to be a successful medication for treating metastatic prostate cancer or prostate cancer after other treatments have failed.
Nuclear Medicine
Consultant
29 years of experience
MIOT International, Chennai
View Doctor
Nuclear Medicine
Director
35 Years
Max Super Speciality Hospital, Saket, New Delhi
View Doctor
Nuclear Medicine
Consultant
25 Years
Max Superspeciality Hospital, Shalimar Bagh, New Delhi
View Doctor
Nuclear Medicine
DNB, MNAMS, FANMB
Fortis Memorial Research Institute, Gurgaon
View Doctor
Nuclear Medicine
MBBS, DNB, Senior Resident
9 years of experience
Fortis Memorial Research Institute, Gurgaon
View Doctor
Nuclear Medicine
MBBS, DNB, FEBNM, Fellow Theranostics
Fortis Memorial Research Institute, Gurgaon
View Doctor
Nuclear Medicine
Ph.D, M.Sc., Clinical Research Officer
Fortis Memorial Research Institute, Gurgaon
View Doctor
By using our site, you agree to our Terms and Conditions, Privacy Policy and Refund Policy. Medsurge India provides reliable healthcare information and treatment options to support informed decision-making. Our content is designed to support and complement the guidance of your treating doctor, helping you feel informed and confident throughout your healthcare journey. We also Accept International Payments.
Copyright © 2025 NSM ONLINE SOLUTIONS PRIVATE LIMITED. All rights reserved.
 (1).png)